DK2196545T3 - Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose - Google Patents

Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose

Info

Publication number
DK2196545T3
DK2196545T3 DK10003542.7T DK10003542T DK2196545T3 DK 2196545 T3 DK2196545 T3 DK 2196545T3 DK 10003542 T DK10003542 T DK 10003542T DK 2196545 T3 DK2196545 T3 DK 2196545T3
Authority
DK
Denmark
Prior art keywords
disseminated sclerosis
predicting
diagnosis
patients
procedures
Prior art date
Application number
DK10003542.7T
Other languages
English (en)
Inventor
Frank Weber
Bertram Mueller-Myhsok
Manfred Uhr
Susanne Lucae
Daria Salyakina
Florian Holsboer
Original Assignee
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft filed Critical Max Planck Gesellschaft
Application granted granted Critical
Publication of DK2196545T3 publication Critical patent/DK2196545T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
DK10003542.7T 2006-02-27 2007-02-27 Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose DK2196545T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06003978A EP1826277A1 (en) 2006-02-27 2006-02-27 Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis
EP07711702A EP1991696B1 (en) 2006-02-27 2007-02-27 Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis

Publications (1)

Publication Number Publication Date
DK2196545T3 true DK2196545T3 (da) 2012-07-16

Family

ID=36658688

Family Applications (2)

Application Number Title Priority Date Filing Date
DK07711702.6T DK1991696T3 (da) 2006-02-27 2007-02-27 Fremgangsmåde til diagnosticering af et anlæg hos patienter med dissemineret sclerose for modtagelighed for interferonterapi samt til diagnosticering af dissemineret sclerose
DK10003542.7T DK2196545T3 (da) 2006-02-27 2007-02-27 Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK07711702.6T DK1991696T3 (da) 2006-02-27 2007-02-27 Fremgangsmåde til diagnosticering af et anlæg hos patienter med dissemineret sclerose for modtagelighed for interferonterapi samt til diagnosticering af dissemineret sclerose

Country Status (7)

Country Link
US (1) US8071299B2 (da)
EP (4) EP1826277A1 (da)
AT (2) ATE466959T1 (da)
DE (1) DE602007006284D1 (da)
DK (2) DK1991696T3 (da)
SI (1) SI2196545T1 (da)
WO (1) WO2007096197A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2207902A1 (en) * 2007-11-09 2010-07-21 INSERM (Institut National de la Santé et de la Recherche Medicale) A method for predicting the therapeutic responsiveness of patients to a medical treatment with an interferon
AU2009273277A1 (en) * 2008-07-24 2010-01-28 Merck Serono S.A. Use of genetic markers for identifying the response to interferon treatment in Multiple Sclerosis patients
WO2011117267A1 (en) * 2010-03-24 2011-09-29 Merck Serono Sa Cladribine treatment of multiple sclerosis in patient groups defined by genotype
EP2380992A1 (en) * 2010-04-21 2011-10-26 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Methods for predicting an antibody response to interfer on therapy in multiple sclerosis patients
WO2018140156A1 (en) * 2017-01-27 2018-08-02 Orig3N, Inc. Systems and methods for determining and presenting purchase recommendations based on personal genetic profiles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1114998A3 (en) 1999-10-28 2001-08-22 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for determining the success rate of treatment of multiple sclerosis
WO2003014319A2 (en) 2001-08-07 2003-02-20 Genaissance Pharmaceuticals, Inc. Polymorphisms associated with multiple sclerosis
SE0103423D0 (sv) 2001-10-12 2001-10-12 Astrazeneca Ab Polymorphism
GB0307914D0 (en) 2003-04-07 2003-05-14 Univ Dundee Cytochrome p450
EP1706507A4 (en) * 2003-11-26 2008-02-20 Univ Ohio State Res Found THE RISK AND PROGRESSION OF MULTIPLE SCLEROSIS PREDICTING POLYMORPHS CD24 GENOTYPES

Also Published As

Publication number Publication date
DE602007006284D1 (de) 2010-06-17
ATE557102T1 (de) 2012-05-15
WO2007096197A3 (en) 2007-10-18
EP1826277A1 (en) 2007-08-29
US8071299B2 (en) 2011-12-06
DK1991696T3 (da) 2010-08-30
EP2196546B1 (en) 2013-02-27
WO2007096197A2 (en) 2007-08-30
EP2196546A1 (en) 2010-06-16
EP2196545A1 (en) 2010-06-16
SI2196545T1 (sl) 2012-09-28
ATE466959T1 (de) 2010-05-15
US20090186773A1 (en) 2009-07-23
EP1991696A2 (en) 2008-11-19
EP1991696B1 (en) 2010-05-05
EP2196545B1 (en) 2012-05-09

Similar Documents

Publication Publication Date Title
WO2007114901A3 (en) Method for diagnosing adhd and related behavioral disorders
EP2083897A4 (en) PATIENT INTERFACE SYSTEMS
DK1984357T3 (da) 2,4-pyrimidindiaminforbindelser til behandling eller forebyggelse af autoimmunsygdomme
WO2007005623A3 (en) System and method for providing individually tailored health-promoting information
DK2046819T3 (da) Fremgangsmåder til forøgelse af secernering af polypeptider med biologisk aktivitet
WO2010101641A3 (en) Galvanic vestibular stimulation system and method of use for simulation, directional cueing, and alleviating motion-related sickness
DE602005001521D1 (de) Spritzenset für Ballonkatheter
EP2001534A4 (en) SYSTEM FOR MONITORING THE COMPLIANCE OF MEDICINAL DOSES
EP1802362A4 (en) NONMAGNETIC MEDICAL INFUSION DEVICE
EP1664752A4 (en) PATIENT POSITIONING SYSTEM FOR RADIOTHERAPY SYSTEM
EP2273918A4 (en) METHODS, SYSTEMS AND DEVICES FOR DETECTING AND DIAGNOSIS OF HEART DISEASES AND DRESSES
EP2061907A4 (en) Tcl1 expression in chronic lymphocytic leukemia (cll) regulated by mir-29 and mir-181
EP2211689A4 (en) VOICE CONTROLLED DASHBOARD WITH CLINICAL INFORMATION
DK1899878T3 (da) Medicinsk behandlingssystem med en indretning til tilvejebringelse af patientrelaterede data
DE602005015418D1 (de) Überwachungssystem für den menschlichen körper
ATE375518T1 (de) Diagnoseverfahren für erkrankungen unter verwendung von copeptin
DK2196545T3 (da) Fremgangsmåder til forudsigelse af reaktionen hos patienter med dissemineret sclerose på interferonbehandling samt diagnosticering af dissemineret sclerose
ITMO20050159A1 (it) Sistema per il controllo dell'umidita'.
DK1817282T3 (da) Til behandling af respiratoriske sygdomme egnede phenoxy derivater
LTPA2018503I1 (lt) Kladribino režimas, skirtas išsėtinei sklerozei gydyti
FI20050263A0 (fi) Hissiryhmä ja menetelmä hissiryhmän ohjaamiseksi
DK2422786T3 (da) Nye lægemiddelkombinationer til behandling af luftvejssygdomme
WO2007100980A3 (en) Electronic contracting
DE602005007576D1 (de) Behandlungsvorrichtung für ein endoskop
WO2005079284A3 (en) Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines